CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model

Journal of Alzheimer's Disease

Volumn 37, Issue 2, 2013, Pages 439-451

  Daschil, Nina ^a   Obermair, Gerald J ^a   Flucher, Bernhard E ^a   Stefanova, Nadia ^a   Hutter Paier, Birgit ^b   Windisch, Manfred ^b   Humpel, Christian ^a   Marksteiner, Josef ^c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b JSW CNS ResearchQPS Austria GmbH   (Austria)

^c General Hospital LKH Hall ^*  (Austria)

Author keywords

Alzheimer's disease; amyloid ; astrocytes

Indexed keywords

AMYLOID BETA PROTEIN; QUINOLINIC ACID; VOLTAGE GATED CALCIUM CHANNEL; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; AMYLOID PRECURSOR PROTEIN; CALCIUM BINDING PROTEIN; CALCIUM CHANNEL L TYPE; GLIAL FIBRILLARY ACIDIC PROTEIN; L-TYPE CALCIUM CHANNEL ALPHA(1C); L TYPE CALCIUM CHANNEL ALPHA(1C);

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; GENE CONTROL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; AGE; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOLOGY; TOXICITY; TRANSGENIC MOUSE; DRUG EFFECT;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; BRAIN; CALCIUM CHANNELS, L-TYPE; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MUTATION; PLAQUE, AMYLOID; QUINOLINIC ACID;

EID: 84883797407     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130560     Document Type: Article

References (42)

1. Thibault O, Gant JC, Landfield PW (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: Minding the store. Aging Cell 6, 307-317.
2. CatterallWA(2000) Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 16, 521-555.
3. Obermair GJ, Flucher BE (2013) Neuronal functions of auxiliary calcium channel subunits. In Modulation of Presynaptic Calcium Channels, Stephens G, Mochida S, Eds. Springer, pp. 365.
4. Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen NK, Busquet P, Pelster G, Singewald N (2006) Role of voltage-gated L-type Ca2+ channel isoforms for brain function. Biochem Soc Trans 34, 903-909.
5. Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, Hoda JC, Sartori SB, Striessnig J (2009) Expression and 1,4-dihydropyridine- binding properties of brain L-type calcium channel isoforms. Mol Pharmacol 75, 407-414.
6. Green KN, Smith IF, LaFerla FM (2007) Role of calcium in the pathogenesis of Alzheimer's disease and transgenic models. Subcell Biochem 45, 507-521.
7. Santos SF, Pierrot N, Octave JN (2010) Network excitability dysfunction in Alzheimer's disease: Insights from in vitro and in vivo models. Rev Neurosci 21, 153-171.
8. Crews L, Rockenstein E, Masliah E (2010) APP transgenic modeling of Alzheimer's disease: Mechanisms of neurodegeneration and aberrant neurogenesis. Brain Struct Funct 214, 111-126.
9. Rockenstein E, Crews L, Masliah E (2007) Transgenic animal models of neurodegenerative diseases and their application to treatment development. Adv Drug Deliv Rev 59, 1093-1102.
10. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gille spie F (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523-527.
11. Willis M, Kaufmann WA, Wietzorrek G, Hutter-Paier B, Moosmang S, Humpel C, Hofmann F, Windisch M, Knaus HG, Marksteiner J (2010) L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutations. J Alzheimers Dis 20, 1167-1180.
12. Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E (2001) Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J Neurosci Res 66, 573-582.
13. Burgess DL, Jones JM, MeislerMH,Noebels JL (1997) Mutation of the Ca2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 88, 385-392.
14. Hansson O, Petersen A, Leist M, Nicotera P, Castilho RF, Brundin P (1999) Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc Natl Acad Sci U S A 96, 8727- 8732.
15. Willis M, Hutter-Paier B, Wietzorrek G, Windisch M, Humpel C, Knaus HG, Marksteiner J (2007) Localization and expression of substance P in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations. Brain Res 1143, 199-207.
16. Schlick B, Flucher BE, Obermair GJ (2010)Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons. Neuroscience 167, 786-798.
17. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034.
18. Hell JW,Westenbroek RE,Warner C, Ahlijanian MK, Prystay W, GilbertMM,Snutch TP, CatterallWA(1993) Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. J Cell Biol 123, 949-962.
19. Obermair GJ, Schlick B, Di B, V, Subramanyam P, Gebhart M, Baumgartner S, FlucherBE(2010) Reciprocal interactions regulate targeting of calcium channel beta subunits and membrane expression of alpha1 subunits in cultured hippocampal neurons. J Biol Chem 285, 5776-5791.
20. Obermair GJ, Tuluc P, Flucher BE (2008) Auxiliary Ca(2+) channel subunits: Lessons learned from muscle. Curr Opin Pharmacol 8, 311-318.
21. Pichler M, Cassidy TN, Reimer D, Haase H, Kraus R, Ostler D, Striessnig J (1997) Beta subunit heterogeneity in neuronal L-type Ca2+ channels. J Biol Chem 272, 13877-13882.
22. HallAM,RobertsonED(2012) Mouse models of Alzheimer's disease. Brain Res Bull 88, 3-12.
23. Sofroniew MV, Vinters HV (2010) Astrocytes: Biology and pathology. Acta Neuropathol 119, 7-35.
24. Ehrlich D, Pirchl M, Humpel C (2012) Effects of long-term moderate ethanol and cholesterol on cognition, cholinergic neurons, inflammation, and vascular impairment in rats. Neuroscience 205, 154-166.
25. Schwab C, McGeer PL (2008) Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis 13, 359-369.
26. Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective. Cell 120, 545-555.
27. PeknyM, NilssonM(2005) Astrocyte activation and reactive gliosis. Glia 50, 427-434.
28. Berridge MJ (2010) Calcium hypothesis of Alzheimer's disease. Eur J Physiol 459, 441-449.
29. Westenbroek RE, Bausch SB, Lin RCS, Franck JE, Noebels JL, Catterall WA (1998) Upregulation of L-Type Ca2+ channels in reactive astrocytes after brain injury, hypomyelination, and ischemia. J Neurosci 18, 2321-2334.
30. Yang L, Wang Z, Wang B, Justice NJ, Zheng H (2009) Amyloid precursor protein regulates Cav1.2 L-type calcium channel levels and function to influence GABAergic shortterm plasticity. J Neurosci 29, 15660-15668.
31. Ferrandiz-Huertas C, Gil-Minguez M, Lujan R (2012) Regional expression and subcellular localization of the voltage-gated calcium channel beta subunits in the developing mouse brain. J Neurochem 122, 1095-1107.
32. DolphinAC (2012) Calcium channel auxiliary -2d and - subunits: Trafficking and one step beyond. Nat Rev Neurosci 13, 542-555.
33. ThalDR(2012) The role of astrocytes in amyloid beta-protein toxicity and clearance. Exp Neurol 236, 1-5.
34. Fiacco TA, McCarthy KD (2006) Astrocyte calcium elevations: Properties, propagation, and effects on brain signaling. Glia 54, 676-690.
35. D'Ascenzo M, Vairano M, Andreassi C, Navarra P, Azzena GB, Grassi C (2004) Electrophysiological and molecular evidence of L-(Cav1), N-(Cav2.2), and R-(Cav2.3) type Ca2+ channels in rat cortical astrocytes. Glia 45, 354-363.
36. Latour I, Hamid J, Beedle AM, Zamponi GW, Macvicar BA (2003) Expression of voltage-gated Ca2+ channel subtypes in cultured astrocytes. Glia 41, 347-353.
37. Chung YH, Shin CM, Kim MJ, Cha CI (2001) Enhanced expression of L-type Ca2+ channels in reactive astrocytes after ischemic injury in rats. Neurosci Lett 302, 93-96.
38. Scragg JL, Fearon IM, Boyle JP, Ball SG, Varadi G, Peers C (2004) Alzheimer's amyloid peptides mediate hypoxic upregulation of L-type Ca2+ channels. FASEB J 19, 150-152.
39. Benedetti B, Matyash V, Kettenmann H (2011) Astrocytes control GABAergic inhibition of neurons in the mouse barrel cortex. J Physiol 589, 1159-1172.
40. Gomez-Ospina N, Panagiotakos G, Portmann T, Pasca SP, Rabah D, Budzillo A, Kinet JP, Dolmetsch RE (2013) A promoter in the coding region of the calcium channel gene CACNA1C generates the transcription factor CCAT. PLoS One 8, e60526.
41. Schubert P, OgataT, Marchini C, Ferroni S (2001) Glia-related pathomechanisms in Alzheimer's disease: A therapeutic target? Mech Ageing Dev 123, 47-57.
42. Escartin C, Bonvento G (2008) Targeted activation of astrocytes: APotential neuroprotective strategy. Mol Neurobiol 38, 231-241.